WHAT MAKES US DIFFERENT
INNOVATION
AQA™ Oral Delivery Technology
nMeds utilizes its proprietary AQA™ (AQASOME™ NPC) oral delivery process to enhance the bioavailability of both pharmaceutical and nutraceutical active ingredients. By nanonizing APIs and ANIs, AQA™ enables consistent, efficient oral absorption—unlocking injection-free delivery for compounds traditionally limited by oral bioavailability.
This innovation allows for more precise dosing, improved patient adherence, and a unified delivery platform across medications, peptides, and functional supplements.
INFRASTRUCTURE
Built to Scale Regulated Healthcare
nMeds is not a consumer brand—we are the infrastructure behind them. Our platform integrates nationwide physician networks, multi-state pharmacy fulfillment, and in-house manufacturing into a single compliant ecosystem.
With telemedicine access, pharmacy execution, and AQA™-powered production under one roof, partners can launch, scale, and operate healthcare and wellness programs without building complex backend systems.
Redefining Peptide Delivery With AQA™ Oral Innovation
At nMeds, we are pioneering the next evolution of peptide therapy through AQA™ Oral Peptide Technology. By transforming traditionally injectable peptides into advanced oral formulations, AQA™ fundamentally changes how these compounds are accessed, prescribed, and experienced. This innovation enables improved patient adherence, greater dosing flexibility, and scalable delivery without compromising scientific integrity or clinical oversight. AQA™ oral peptides represent a shift away from needles and limitations, and toward a future where advanced therapeutics are more accessible, personalized, and practical. As the infrastructure behind this transformation, nMeds combines nationwide physician networks, pharmacy fulfillment, and in-house manufacturing to bring AQA™ oral peptides to market responsibly and at scale. This is not a trend—it is a structural change in how peptide-based care will be delivered moving forward. The landscape is changing. AQA™ oral peptides are leading it.
nMeds is redefining how advanced therapeutics are delivered by combining AQA™ oral delivery solution with a fully integrated healthcare infrastructure. By converting complex pharmaceutical compounds and peptides into reliable oral formats, we remove traditional barriers to access while improving patient adherence and consistency of care.
This approach allows physicians to prescribe with greater flexibility, enables partners to scale responsibly, and gives patients a more practical path to long-term wellness. Through innovation, infrastructure, and clinical oversight, nMeds is helping shape a future where feeling better is not delayed by complexity… it begins with better delivery.
ORAL GLP-1 SEMAGLUTIDE
Experience the ease and flexibility of AQA Oral Semaglutide – your daily dose for control and convenience without the needles. Choose comfort and customization over traditional injectables.
Oral Semaglutide offers a range of benefits
One of the key advantages is its ease of administration, as it is taken orally, eliminating the need for injections and making it a more comfortable and convenient choice for daily use. This method of administration also provides greater flexibility in dosing, allowing patients to adjust their intake within prescribed limits to better manage their symptoms and treatment responses. Additionally, oral Semaglutide offers the convenience of easy storage and transport, without the need for refrigeration, making it a practical solution for those with busy lifestyles or who travel frequently. Overall, oral Semaglutide combines effectiveness with patient-friendly features, enhancing adherence to treatment plans and improving overall quality of life.
1.Administration Method: Taken orally, in the form of daily drops, making it non-invasive.
2.Dosing Flexibility: Offers more flexibility as patients can adjust their dosing within a prescribed range, allowing for a personalized approach.
3.Absorption and Bioavailability: Absorption may be less consistent compared to injections due to the oral route, and bioavailability may vary.
4.Convenience: More convenient as it eliminates the need for injections, making it easier for daily use and travel.
5.Control Over Dosing: Allows patients to have greater control over their dosing, which can be beneficial in managing side effects and response to treatment.
6.Storage and Handling: Easier to store and handle, generally does not require refrigeration.
Injectable GLP-1 Semaglutide Has many challenges
While effective, comes with several disadvantages that can impact patient experience and adherence. The need for regular injections can be uncomfortable and inconvenient for many patients, leading to potential apprehension or needle-related anxiety. Additionally, the requirement for refrigeration complicates storage and travel, making it less practical for those with active lifestyles or frequent travel plans. The fixed dosing regimen also limits flexibility, requiring medical consultation for any adjustments, which can be less adaptable to individual patient needs. These factors can contribute to reduced patient compliance and overall satisfaction with the treatment.
1.Administration Method: Administered via subcutaneous injection, typically once a week.
2.Dosing Flexibility: Dosing is usually fixed and must be followed as per the prescribed regimen.
3.Absorption and Bioavailability: Direct injection into the bloodstream provides consistent absorption and high bioavailability.
4.Convenience: Requires regular injections, which some patients may find inconvenient or uncomfortable.
5.Control Over Dosing: Patients have limited control over dosing once administered; changes require medical consultation.
6.Storage and Handling: Requires refrigeration and careful handling, particularly when traveling.
what our clients have to say
Numerous medications necessitating oral delivery could revolutionize cancer treatment for patients. The complexities of cancer treatments often lead to various complications, and an oral solution has the potential to significantly assist patients throughout the process.
Discovering the availability of oral compounding for medications brought us great enthusiasm. This option will be particularly beneficial for our families, especially as we care for children and youth.
The utilization of low-dose oral delivery has proven remarkably effective for the microdosing of medications.
